63rd Annual Meeting of the American Association for the Study of Liver Disease (AASLD), 9-13 November 2012, Boston
The 2012 “Liver Meeting” was held in the US just prior to the Glasgow conference. This report from Tracy Swan provides and excellent overview of the exciting developments for both HCV monoinfection and HIV/HCV coninfection.
Early front-runners include two in-house combinations, each from Abbott and Gilead, but these are early days and a lot can happen between phase 2 studies and regulatory submission – and there are over 60 pipeline compounds in development.
Abstracts from the meeting can be viewed online using the itinerary planner on the conference website. This requires a free login and is searchable, but uses a format that does not allow including direct URL links to each abstract.
Reports in this issue are: